CARLOS
SOLANO VERCET
CATEDRÁTICO/A DE UNIVERSIDAD
University Hospital of Geneva
Ginebra, SuizaPublicaciones en colaboración con investigadores/as de University Hospital of Geneva (2)
2021
-
Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT
Bone Marrow Transplantation, Vol. 56, Núm. 7, pp. 1593-1602
2017
-
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380